Filarial antigenemia and Bm14 antibody rates in subjects with microfilaremia before and after mass drug administration (MDA).
收藏NIAID Data Ecosystem2026-03-07 收录
数据链接：
官方服务：
资源简介：
Data shown are the number of subjects with positive tests and the number of Mf-positive subjects tested (% positive) before the first round of MDA and approximately 12 months after each round of MDA. Abbreviations: Mf, microfilaremia; CFA, circulating filarial antigenemia; Bm14, IgG4 antibodies to recombinant filarial antigen Bm14.
创建时间：
2013-02-21
